ADC	directed antibody-drug conjugate
AKT	the serine/threonine protein kinase
ALK	Anaplastic lymphoma kinase
APC	antigen presenting cells
ATF4	Activating Transcription Factor 4
BC	breast cancer
BL1	basal-like 1
BL2	basal-like 2
BRCA	BReast CAncer gene
CDK	Cicline dependent kinase
CI	confidance interval
CPS	combined positive score
ECM	extracellular matrix
EGFR	Epidermal Growth Factor Receptor
EMA	European Medicine Agency
ER	estrogen receptor
ETM	epithelial to mesenchymal transition
FAK	focal adhesion kinase
G-CSF	Granulocyte Colony-Stimulating Factor
GSIs	γ -secretase inhibitors
HER2	epidermal growth factor receptor-2
HIF1	Hypoxia-Inducible Factor
HR	hazard ratio
IFN-γ	Interferon gamma
IGF-1R	Insulin-like growth factor 1
IM	immunomodulatory
JAK	Janus-family tyrosine kinase
LAR	luminal androgen receptor
M	mesenchymal-like
MAPK	Mitogen-activated protein kinase
MDSCs	suppressor cells of myeloid derived origin
MET	mesenchymal-epithelial transition factor
MSL	mesenchymal stem cell-like
mTOR	mammalian target of rapamycin
MVA	Modified Vaccinia Ankara
NACT	neoadjuvant chemotherapy
NSCLC	no small cell lung cancer
ORR	objective response rate
OS	overall survival
PARP	Poli ADP-ribose polymerase inhibitors
pCR	pathological complete response
PD-1	programmed death-1
PDGF	Platelet-Derived Growth Factor
PD-L1	Programmed Death-Ligand 1
PFS	progression free survival
PI3K	phosphatidylinositol-3-OH kinase
PR	progesterone receptor
PTEN	tensin homologue
RTKs	Receptor tyrosine kinases
SFKs	Src family kinases
SH	Src homology
Src	sarcoma oncogene cellular homolog
STAT	Signal transducer and activator of transcription
TGF-β	Tumor Necrosis Factor Beta
TKI	tyrosine kynase inhibitor
TNBC	triple negative breast cancer
TP53	Tumor protein53
Trop-2	trophoblast cell surface antigen-2
VEGF	vascular endothelial growth factors